Search Results - N. Z Musina

THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES by N. Z. Musina, V. K. Fedyaeva

Connect to this object online.

PROSPECTS FOR THE USE OF METHODS OF ECONOMIC EVALUATION AT THE STAGE OF PLANNING AND ORGANISATION OF CLINICAL TRIALS by N. Z. Musina, V. V. Tarasov

Connect to this object online.

Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system by T. S. Teptsova, N. Z. Musina, V. V. Omelyanovsky

Connect to this object online.

EARLY HEALTH TECHNOLOGIES ASSESSMENT - NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS by N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova

Connect to this object online.

Introduction of medical products into healthcare practice and costs reimbursement: European experience by V. V. Omelyanovsky, S. S. Otstavnov, N. Z. Musina, V. S. Dombrovskii

Connect to this object online.

The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia by V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina

Connect to this object online.

Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making by V. A. Lemeshko, N. Z. Musina, V. V. Omelyanovskiy

Connect to this object online.

IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET by V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva

Connect to this object online.

Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions by G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina

Connect to this object online.

Evolution of healthcare provider payment mechanisms by V. V. Omelyanovskiy, N. N. Sisigina, V. K. Fedyaeva, N. Z. Musina

Connect to this object online.

Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential dr... by T. O. Bessonova, P. A. Mukhortova, R. A. Teryan, A. D. Bagdasarov, N. Z. Musina

Connect to this object online.

Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies by T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov

Connect to this object online.

International experience in determining the cost-effectiveness thresholds by T. P. Bezdenezhnykh, N. Z. Musina, V. K. Fedyaeva, T. S. Tepcova, V. A. Lemeshko, V. V. Omelyanovsky

Connect to this object online.

Pharmacoeconomic analysis of the application of follitropin alfa in combination with assisted reproductive technologies by K. A. Perova, D. G. Shchurov, D. V. Blinov, N. V. Bashmakova, N. Z. Musina

Connect to this object online.

THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS by V. K. Fedyaeva, V. V. Omelyanovskiy, N. Z. Musina, G. R. Khachatryan, O. I. Ivakhnenko

Connect to this object online.

Affordability of in vivo gene therapy. Problems and potential solutions by V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko

Connect to this object online.

Concept of value-based healthcare by N. Z. Musina, V. V. Omelyanovskiy, R. V. Gostischev, O. A. Sukhorukikh, V. K. Fedyaeva, N. N. Sisigina, D. G. Shchurov

Connect to this object online.

Review of the current approaches to the assessment of the drug innovative potential worldwide by N. Z. Musina, V. K. Fedyaeva, V. V. Omel'yanovskii, G. R. Khachatryan, K. V. Gerasimova, V. A. Lemeshko, K. P. Konchits

Connect to this object online.